Stress ulcer prophylaxis in the postoperative period

American Journal of Health-System Pharmacy

Volumn 61, Issue 6, 2004, Pages 588-596

  Allen, Michelle E ^a   Kopp, Brian J ^b   Erstad, Brian L ^c  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

American Society of Health System Pharmacists; Gastrointestinal agents; Protocols; Stress; Surgery; Ulcers

Indexed keywords

CIMETIDINE; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PIRENZEPINE; PLACEBO; PROTON PUMP INHIBITOR; RANITIDINE; SUCRALFATE; ANTIULCER AGENT;

ALUMINUM OVERLOAD; BLOOD TRANSFUSION; CLINICAL TRIAL; HELICOBACTER PYLORI; HEMODYNAMICS; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE; PNEUMONIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; STRESS ULCER; THROMBOCYTOPENIA; ECONOMICS; PEPTIC ULCER; PEPTIC ULCER BLEEDING; POSTOPERATIVE CARE; PREMEDICATION; RISK FACTOR; STANDARD; STRESS;

ANTI-ULCER AGENTS; HUMANS; PEPTIC ULCER; PEPTIC ULCER HEMORRHAGE; POSTOPERATIVE CARE; PRACTICE GUIDELINES; PREMEDICATION; RISK FACTORS; STRESS;

EID: 2342447376     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/61.6.588     Document Type: Review

References (41)

1. American Society of Health-System Pharmacists. ASHP therapeutic guidelines on stress ulcer prophylaxis. Am J Health-Syst Pharm. 1999; 56:347-79.
2. Guyatt GH, Sackett DL, Sinclair JC et al. Users' guides to the medical literature: IX. A method for grading health care recommendations. JAMA. 1995; 274: 1800-4.
3. Cook DJ, Guyatt GH, Laupacis A et al. Clinical recommendations using levels of evidence for antithrombotic agents. Chest. 1995; 108(4, suppl):S227-30.
4. Erstad BL. Concerns with defining appropriate uses of albumin by meta-analysis. Am J Health-Syst Pharm. 1999; 56:1451-4.
5. Cook D, Guyatt G, Marshall J et al. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. N Engl J Med. 1998; 338:791-7.
6. Van der Voort PH, van der Hulst RW, Zandstra DF et al. Prevalence of Helicobacter pylori infection in stress-induced gastric mucosal injury. Intensive Care Med. 2001; 27:68-73.
7. Robertson MS, Cade JF, Clancy RL. Helicobacter pylori infection in intensive care: increased prevalence and a new nosocomial infection. Crit Care Med. 1999; 27: 1276-80.
8. Halm U, Halm F, Thein D et al. Helicobacter pylori infection: a risk factor for upper gastrointestinal bleeding after cardiac surgery? Crit Care Med. 2000; 28: 110-3.
9. Schilling D, Haisch G, Sloot N et al. Low seroprevalence of Helicobacter pylori infection in patients with stress ulcer bleeding. Intensive Care Med. 2000; 26:1832-6.
10. Stchepinsky OA, Theodose YV, Huisman JP et al. Prevention of gastrointestinal bleeding after a cardiac operation. Ann Thorac Surg. 1998; 66:296-7. Letter.
11. Cook D, Heyland D, Griffith L et al. Risk factors for clinically important upper gastrointestinal bleeding in patients requiring mechanical ventilation. Crit Care Med. 1999; 27:2812-7.
12. Devlin JW, Claire KS, Dulchavsky SA et al. Impact of trauma stress ulcer prophylaxis guidelines on drug cost and frequency of major gastrointestinal bleeding. Pharmacotherapy. 1999; 19:452-60.
13. Kuusela AL, Mäki M, Ruuska T et al. Stress-induced gastric findings in critically ill newborn infants: frequency and risk factors. Intensive Care Med. 2000; 26: 1501-6.
14. Yildizdas D, Yapicioglu H, Yilmaz HL. Occurrence of ventilator-associated pneumonia in mechanically ventilated pediatric intensive care patients during stress ulcer prophylaxis with sucralfate, ranitidine, and omeprazole. J Crit Care. 2002; 17:240-5.
15. Hanisch EW, Encke A, Naujoks F et al. A randomized, double-blind trial for stress ulcer prophylaxis shows no evidence of increased pneumonia. Am J Surg. 1998; 176:453-7.
16. Messori A, Trippoli S, Vaiani M et al. Bleeding and pneumonia in intensive care patients given ranitidine and sucralfate for prevention of stress ulcer: meta-analysis of randomised controlled trials. BMJ. 2000; 321:1-7.
17. Cook DJ, Reeve BK, Guyatt GH et al. Stress ulcer prophylaxis in critically ill patients: resolving discordant meta-analyses. JAMA. 1996; 275:308-14.
18. Cook DJ, Fuller HD, Guyatt GH et al. Risk factors for gastrointestinal bleeding in critically ill patients. N Engl J Med. 1994; 330:377-81.
19. Terdiman JP, Ostroff JW. Gastrointestinal bleeding in the hospitalized patient: a case-control study to assess risk factors, causes, and outcome. Am J Med. 1998; 104:349-54.
20. Roberts KW, Pitcher WD, Cryer B. Effect of lansoprazole suspension versus continuous intravenous ranitidine on gastric pH of mechanically ventilated intensive care unit patients. Crit Care Med. 2000; 28:A185. Abstract.
21. Bergman KL, Kaufman S, Collier D et al. Pharmacodynamics of omeprazole suspension in critically ill pediatric liver/ intestinal transplant patients. Crit Care Med. 1999; 27:A171. Abstract.
22. Kaufman SS, Lyden ER, Brown CR et al. Omeprazole therapy in pediatric patients after liver and intestinal transplantation. J Pediatr Gastroenterol Nutr. 2002; 34:194-8.
23. Phillips JO, Olsen KM, Rebuck JA et al. A randomized, pharmacokinetic and pharmacodynamic, cross-over study of duodenal or jejunal administration compared to nasogastric administration of omeprazole suspension in patients at risk for stress ulcers. Am J Gastroenterol. 2001; 96:367-72.
24. Mulla H, Peek G, Upton D et al. Plasma aluminum levels during sucralfate prophylaxis for stress ulceration in critically ill patients on continuous venovenous hemofiltration: a randomized, controlled trial. Crit Care Med. 2001; 29:267-71.
25. Stephan F, Hollande J, Richard O et al. Thrombocytopenia in a surgical ICU. Chest. 1999; 115:1363-70.
26. Cawley MJ, Wittbrodt ET, Boyce EG et al. Potential risk factors associated with thrombocytopenia in a surgical intensive care unit. Pharmacotherapy. 1999; 19: 108-13.
27. Ibrahim EH, Tracy L, Hill C et al. The occurrence of ventilator- associated pneumonia in a community hospital. Chest. 2001; 120:555-61.
28. Mallow S, Ahern J. Nosocomial pneumonia and related complications in the critically ill trauma patient: does choice of proton pump inhibitor versus histamine antagonist influence infection? Crit Care Med. 2002; 30:A118. Abstract.
29. Lopriore E, Markhorst DG, Gemke RJ. Ventilator-associated pneumonia and upper airway colonisation with gram negative bacilli: the role of stress ulcer prophylaxis in children. Intensive Care Med. 2002; 28:763-7.
30. Protonix package insert. Philadelphia, PA: Wyeth Pharmaceuticals; 2003 Jul.
31. 2-receptor antagonist in intensive care unit patients. Crit Care Med. 2001; 29: A147. Abstract.
32. Barletta JF, Erstad BL, Fortune JB. Stress ulcer prophylaxis in trauma patients. Crit Care. 2002; 6:526-30.
33. Bradley JS, Phillips JO, Cavanaugh JE et al. Clinical utility of pH paper versus pH meter in the measurement of critical gastric pH in stress ulcer prophylaxis. Crit Care Med. 1998; 26:1905-9.
34. Lugo RA, Harrison AM, Cash J et al. Pharmacokinetics and pharmacodynamics of ranitidine in critically ill children. Crit Care Med. 2001; 29:759-64.
35. Erstad BL. Proton-pump inhibitors for acute peptic ulcer bleeding. Ann Pharmacother. 2001; 35:730-40.
36. Zed PJ, Loewen PS, Slavik RS et al. Meta-analysis of proton pump inhibitors in treatment of bleeding peptic ulcers. Ann Pharmacother. 2001; 35:1528-34.
37. Conrad SA. Acute upper gastrointestinal bleeding in critically ill patients: causes and treatment modalities. Crit Care Med. 2002: 30(suppl):S365-8.
38. Lam NP, Le PD, Crawford SY et al. National survey of stress ulcer prophylaxis. Crit Care Med. 1999; 27:98-103.
39. Schupp KN, Schrand LM, Mutnick AH. A cost-effectiveness analysis of stress ulcer prophylaxis. Ann Pharmacother. 2003; 37:631-5.
40. Pitimana-aree S, Forrest D, Brown G et al. Implementation of a clinical practice guideline for stress ulcer prophylaxis increases appropriateness and decreases cost of care. Intensive Care Med. 1998; 24:217-23.
41. Mostafa G, Sing RF, Matthews BD et al. The economic benefit of practice guidelines for stress ulcer prophylaxis. Am Surg. 2002; 68:146-50.